A detailed history of Inceptionr LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Inceptionr LLC holds 11,307 shares of AXGN stock, worth $218,112. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,307
Previous 14,696 23.06%
Holding current value
$218,112
Previous $206 Million 9.56%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

SELL
$12.47 - $17.19 $42,260 - $58,256
-3,389 Reduced 23.06%
11,307 $186 Million
Q3 2024

Nov 08, 2024

BUY
$7.52 - $14.69 $110,513 - $215,884
14,696 New
14,696 $206 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $816M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.